PharmaShots | Incisive News in 3 Shots

Subscribe Now

Humira

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

March 29, 2023

Alvotech Reports the US FDA and EMA's Acceptance of AVT02 Proposed Biosimilar to Humira (adalimumab)

Alvotech Reports the US FDA and EMA's Acceptance of AVT02 Proposed Biosimilar to Humira (adalimumab)

November 20, 2020

Top 20 Prescription Drugs Based on 2019 Revenue

Top 20 Prescription Drugs Based on 2019 Revenue

July 17, 2020

Insights+ Key Biosimilars Events of May 2020

Insights+ Key Biosimilars Events of May 2020

June 5, 2020

Alvotech Reports Results of AVT02 (a proposed biosimilar to adalimumab) in Two Clinical Studies for Autoimmune Diseases

Alvotech Reports Results of AVT02 (a proposed biosimilar to adalimumab) in Two Clinical Studies for Autoimmune Diseases

May 13, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us